Literature DB >> 10864662

Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase.

P L Boyer1, S H Hughes.   

Abstract

We compared the fidelity of wild-type human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) and two RT mutants, Y115F and Y115V. Although neither mutation had a large effect on the overall fidelity of the enzyme, both mutations altered the spectrum of mutations and the precise nature of the mutational hot spots. The effects of Y115V were greater than those of Y115F. When we compared the behavior of the wild-type enzyme with published data, we found that, in contrast to what has been published, misalignment/slippage could account for only a small fraction of the mutations we observed. We also found that a preponderance of the mutations (both transitions and transversions) resulted in the insertion of an A. Because we were measuring DNA-dependent DNA synthesis (plus-strand synthesis), this bias could contribute to the A-rich nature of the HIV-1 genome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864662      PMCID: PMC112158          DOI: 10.1128/jvi.74.14.6494-6500.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Mutagenesis by transient misalignment.

Authors:  T A Kunkel; A Soni
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

4.  Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89.

Authors:  M Tisdale; T Alnadaf; D Cousens
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  HIV genetic variation is directed and restricted by DNA precursor availability.

Authors:  J P Vartanian; U Plikat; M Henry; R Mahieux; L Guillemot; A Meyerhans; S Wain-Hobson
Journal:  J Mol Biol       Date:  1997-07-11       Impact factor: 5.469

6.  The impact of multidideoxynucleoside resistance-conferring mutations in human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and error specificity.

Authors:  L F Rezende; K Curr; T Ueno; H Mitsuya; V R Prasad
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.

Authors:  D Arion; N Kaushik; S McCormick; G Borkow; M A Parniak
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

8.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

9.  Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.

Authors:  J Ding; K Das; Y Hsiou; S G Sarafianos; A D Clark; A Jacobo-Molina; C Tantillo; S H Hughes; E Arnold
Journal:  J Mol Biol       Date:  1998-12-11       Impact factor: 5.469

10.  Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.

Authors:  P R Meyer; S E Matsuura; A G So; W A Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more
  20 in total

1.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

2.  The cost of replication fidelity in an RNA virus.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

3.  Biochemical studies on the mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to 1-(beta-D-dioxolane)thymine triphosphate.

Authors:  Johan Lennerstrand; Chung K Chu; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

4.  In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT.

Authors:  Paul L Boyer; Carolyn R Stenbak; David Hoberman; Maxine L Linial; Stephen H Hughes
Journal:  Virology       Date:  2007-07-12       Impact factor: 3.616

5.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

6.  Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.

Authors:  Renxiang Chen; Masaru Yokoyama; Hironori Sato; Cavan Reilly; Louis M Mansky
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 7.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

8.  The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.

Authors:  Kelly J Huang; Gerald M Alter; Dawn P Wooley
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

9.  The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.

Authors:  Michal Entin-Meer; Ziv Sevilya; Amnon Hizi
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.

Authors:  Galina N Nikolenko; Evguenia S Svarovskaia; Krista A Delviks; Vinay K Pathak
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.